Felicetto Ferrara

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

Miguel Á. Sanz, Francesco Lo‐Coco, Giuseppe Avvisati et al. · PubMed · 2000 · 632 citations

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

Angela Nebbioso, Nicole Clarke, Emilie Voltz et al. · Nature Medicine · 2004 · 617 citations

Hematological Malignancy, Hdac Inhibitors, Oncology +11

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 551 citations · Full text

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

Robin Foà, Renato Bassan, Antonella Vitale et al. · New England Journal of Medicine · 2020 · 467 citations · Full text